Cohort 1: 1.0 x 10^8 PolyTregs ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
35天疱瘡1

35. 天疱瘡


臨床試験数 : 99 薬物数 : 124 - (DrugBank : 36) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 169
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03239470
(ClinicalTrials.gov)
October 10, 20172/8/2017Polyclonal Regulatory T Cells (PolyTregs) for PemphigusA Phase I, Open-Label, Multicenter Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults With Active Pemphigus (APG01)Pemphigus Foliaceus;Pemphigus VulgarisBiological: Cohort 1: 1.0 x 10^8 PolyTregs;Biological: Cohort 2: 2.5x10^8 PolyTregsNational Institute of Allergy and Infectious Diseases (NIAID)Autoimmunity Centers of Excellence;Rho Federal Systems Division, Inc.Active, not recruiting18 Years75 YearsAll5Phase 1United States